Biotechnology company Moderna (NASDAQ:MRNA) reported Q1 CY2026 results topping the market’s revenue expectations, with sales ...

Moby Strategic Performance and Operational Context. Revenue growth of $0.4 billion in Q1 was primarily driven by the ...

Reports first quarter revenue of $0.4 billion, with approximately 80% of revenue from international marketsReports ...

By Julie Steenhuysen May 1 (Reuters) - Moderna surpassed Wall Street estimates for first-quarter revenue on Friday, helped by ...

Moderna Inc. MRNA shares fell Friday after the company reported a quarterly net loss driven by a litigation settlement charge ...

Moderna (MRNA) beats 1Q26 revenue on international COVID sales, cuts costs, and eyes mRNA-1010 flu PDUFA Aug 5.

aDepartment of Obstetrics and Gynecology and Center on Human Development and Disability (CHDD), University of Washigton School of Medicine, Seattle, WA, USA ...

Zurich (Switzerland), April 20, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announces ...

FDA reversal, patent relief, and mRESVIA risks show a commoditized market and lofty $20B valuation. See more here.

In these guidelines, the American Heart Association provides updated guidance for resuscitation of adults and children in cardiac arrest or with a life-threatening condition due to special ...